SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 234.68 |
| Enterprise Value ($M) | 226.99 |
| Book Value ($M) | 8.06 |
| Book Value / Share | 0.07 |
| Price / Book | 29.11 |
| NCAV ($M) | 7.56 |
| NCAV / Share | 0.06 |
| Price / NCAV | 31.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | -0.66 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 27.39 |
| Current Ratio | 27.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.84 |
| Assets | 8.35 |
| Liabilities | 0.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.01 |
| Operating Income | -5.74 |
| Net Income | -5.49 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -5.30 |
| Cash from Investing | 6.32 |
| Cash from Financing | 1.45 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,335 | 35,081 | 18.06 | |
| 2,131 | 40,819 | 5.22 | |
| 9,225 | 34,780 | 26.52 | |
| 7,247 | 42,531 | 17.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CDIO – Cardio Diagnostics Holdings, Inc. | CDTX – Cidara Therapeutics, Inc. |
| CELU – Celularity Inc. | CGEN – Compugen Ltd. |
| CGTX – Cognition Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io